To improve care, policy analysts and health leaders recommend there be fewer and narrower quality measures.
To improve care, policy analysts and health leaders recommend there be fewer and narrower quality measures.
Tom Daschle, former Senate majority leader from South Dakota, and Michael Leavitt, former governor of Utah and Department of Health and Human Services Secretary under George W. Bush, say that in order for the US healthcare system to transition to a focus on value, a unified group of measures is necessary.
“The dilemma we are having in driving quality measurement is we are still trying to fuss with the little gears,” Leavitt said. “We are going to have to discover the big gears and turn them. That’s all the consumer has interest in dealing with.”
Currently, providers manage about 1370 different performance measures, and many are unaligned. With policy reform initiatives such as HITECH and the Affordable Care Act, that number is subject to increase.
Leavitt adds, “You can implement just about any system in time. We’ve been going through a complicated, labored implementation. But you have to ask the question now, `is it working, and how can we make it better where it’s not working?’”
Quantifying quality benchmarks is important, especially as changes to the sustainable growth rate formula will impact Medicare incentive programs. In addition to providers receiving a 0.5% annual increase in reimbursement and other bonuses, the newly minted merit-based incentive payment system will combine the Physician Quality Reporting System along with meaningful use and value-based payment modifier programs.
“This legislation represents a major milestone in physicians’ nearly 10-year battle to repeal the flawed sustainable growth rate formula used to calculate Medicare reimbursement,” said David W. Parke II, MD, CEO of the American Academy of Ophthalmology. “The Academy applauds the efforts of the members of the Senate Committee on Finance, the House Committee on Ways and Means, and the House Committee on Energy and Commerce for their efforts in developing this bipartisan legislation. Ophthalmology joins our colleagues across medicine in strongly urging lawmakers to pass this legislation in order to protect the viability of physicians’ practices and ensure beneficiaries have access to the highest quality medical and surgical care available.”
Around the Web
Leaders Press for Fewer Quality Measures [Healthcare IT News]
Support for SGR Repeal Bill Builds Among Physician Societies [EHR Intelligence]
Integrating RECIST and Clinician Approaches Boosts NSCLC Research
May 8th 2024Outcomes among patients with stage IV non–small cell lung cancer as evaluated within clinical trials via Response Evaluation Criteria in Solid Tumors (RECIST) and clinician response criteria in observational studies were compared for their concordance and reliability.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
The Joint Commission is launching the Rural Health Clinic Accreditation Program to standardize staff training and patient care practices at rural health clinics nationwide; the American Cancer Society recently launched the largest-ever study of cancer risk and outcomes in Black women; the HHS COVID-19 vaccination campaign saved $732 billion by preventing illness and related costs.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
AA Unlikely to Cause Anxiety, Depression but May Be Affected by Mental Illness
May 7th 2024A Mendelian randomization study using genetic analysis found that alopecia areata (AA) increases the risk of anxiety and depression, but not the other way around, providing unique evidence for a causal link while adding to existing evidence.
Read More